Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Colin Berry
,
Raoul Bonan
Added:
3 years ago
Aortic Stenosis and Suitability for Aortic Valve Replacement
Aortic stenosis is the most common form of adult valvular heart disease. In North America, the estimated population incidence of moderate-severe aortic stenosis (valve area <1.5cm2) is 0.4%, rising to 2.8% in subjects aged ≥75 years. In the EuroHeart Survey of 216 elderly patients (≥75 years) who had severe aortic stenosis (≤0.6 cm2…
View more
Author(s):
Florian Hecker
,
Mani Arsalan
,
Thomas Walther
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) has become the default treatment option for high-risk patients with aortic stenosis (AS) and, based on heart team discussion, an alternative to surgical aortic valve replacement (SAVR) in intermediate-risk patients.
TAVR has led to a paradigm shift in the basic therapeutic principle to treat AS: calcifications, in some patients quite excessive, are…
View more
Author(s):
Roberto Spina
,
Chris Anthony
,
David WM Muller
,
et al
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) with either the balloonexpandable Edwards SAPIEN XT valve (Edwards Lifesciences, Irvine, California), or the self-expandable CoreValve prosthesis (Medtronic, Minneapolis, Minnesota) has become the established therapeutic modality for severe aortic valve stenosis in patients who are not deemed suitable for surgical intervention due to excessively high…
View more
TAVR in Bicuspid Disease
Author(s):
Nicolas M Van Mieghem
,
Basel Ramlawi
,
Didier Tchétché
,
et al
Start date:
Jun 04, 2020
Broadcast
Author(s):
Lars G Svensson
Added:
3 years ago
If you can look into the seeds of time and say which grain will grow and which will not speak then to me. Macbeth; William Shakespeare.
Predictions of the role of transcatheter aortic valve replacement (TAVR) in moderate-risk patients is fraught with potential pitfalls. The matrix of outcomes is interlinked and changes in one cell may have consequences beyond currently observable measures. For…
View more
Impact on Implantation Depth
Author(s):
Verena Veulemans
,
Oliver Maier
,
Tobias Zeus
Added:
1 month ago
Article
Author(s):
Hemal Gada
,
Kendra J Grubb
Added:
1 year ago
Dr Hemal Gada (UPMC Heart and Vascular Institute, US) and his team published an informative review article on “Transcatheter Aortic Valve Replacement Optimization Strategies: Cusp Overlap, Commissural Alignment, Sizing, and Positioning”, in a comprehensive special focus issue on the “Lifetime Management of Patients With Aortic Stenosis” edited byDr Kendra Grubb(Emory Structural Heart and Valve…
View more
Author(s):
Basel Ramlawi
,
Mahesh Ramchandani
,
Michael J Reardon
Added:
3 years ago
Symptomatic severe aortic stenosis or insufficiency have no effective medical treatments and carry a dismal prognosis if left untreated. Since the first aortic valve replacement in 1960, hundreds of thousands of lives have been saved and improved by this procedure. Until recently, surgical aortic valve replacement (sAVR) was the only effective therapy for severe aortic valve stenosis. The recent…
View more
Author(s):
Marko Banovic
Added:
2 years ago
In this short video interview, Dr Marko Banovic (Clinical centre of Serbia, Belgrade, RS) discusses the AVATAR Trial. The trial evaluated aortic valve replacement (AVR) compared with conservative therapy among patients with asymptomatic severe aortic stenosis.
Presented first at AHA 2021, the trial showed that early AVR was beneficial at preventing adverse events among patients with asymptomatic…
View more